Age-related macular degeneration affects approximately 196 million people worldwide and is a leading cause of visual impairment. In this JAMA podcast, JAMA Deputy Editor Mary McGrae McDermott, MD, interviews author Usha Chakravarthy, MD, PhD, Queen’s University of Belfast, Northern Ireland, about the causes, diagnosis, and treatment of age-related macular degeneration. Related Content: Age-Related Macular Degeneration

JAMA editors highlight top 2023 Clinical Reviews podcasts, including cirrhosis management, heart failure treatments, worsening US maternal death rates, and addressing obstetric racism.

Perinatal mental health conditions are a leading cause of overall and preventable maternal mortality. JAMA Deputy Editor Linda Brubaker, MD, MS, discusses postpartum depression with author Tiffany A. Moore Simas, MD, MPH, MEd, chair of the Department of Obstetrics and Gynecology at the University of Massachusetts. Related Content: A Fast-Acting Pill Received Approval for Postpartum Depression—Is It a Game Changer? Postpartum Depression—New Screening Recommendations and Treatments

Discover the diagnosis and treatment of Morton neuroma, plantar fasciitis, and Achilles tendinopathy. Learn about diagnostic tests for Morton's neuroma, the use of eccentric exercises for Achilles tendonitis, and the risk factors associated with Achilles tendonitis. Explore novel treatments like platelet-rich plasma and extra-corporeal shockwave therapy for foot disorders.

Dr. Denice Feig, professor of medicine at the University of Toronto, talks about using metformin for diabetes in pregnancy, discussing new trials and benefits such as improved glycemic control and reduced maternal weight gain. The podcast also highlights the need for more research on long-term effects of metformin on obesity and diabetes risk in children.

Deaths during pregnancy and in the early postpartum period have increased in the US over the past several years, and approximately 80% of these deaths are considered preventable. JAMA Senior Editor Kristin L. Walter, MD, MS, speaks with Sadiya S. Khan, MD, MSc, from Northwestern University about the importance of monitoring and improving cardiovascular health during the postpartum period. Related Content: Cardiovascular Health in the Postpartum Period

Obesity affects approximately 42% of adults in the US. Multiple strategies are available to treat obesity, including behavior therapies, GLP-1 receptor agonists, and bariatric surgery. Therapies vary in effectiveness and risks. JAMA Deputy Editor Mary McGrae McDermott, MD, discusses evidence-based obesity treatment with Melanie Jay, MD, MS, New York University Grossman School of Medicine. Related Content: Obesity Management in Adults As Semaglutide’s Popularity Soars, Rare but Serious Adverse Effects Are Emerging FDA Green-Lights Tirzepatide, Marketed as Zepbound, for Chronic Weight Management

Critical bleeding is associated with a high mortality rate in patients with trauma. JAMA Associate Editor Christopher W. Seymour, MD, MSc, discuses the results of the CRYOSTAT-2 trial with Nicola Curry, MD, Oxford University Hospitals, and Ross Davenport, PhD, Centre for Trauma Sciences, UK. Related Content: Early and Empirical High-Dose Cryoprecipitate for Hemorrhage After Traumatic Injury

In July 2023, the US Food and Drug Administration (FDA) approved the first oral contraceptive pill (Opill) that will be available without a prescription. JAMA Senior Editor Kristin Walter, MD, MS, spoke with JAMA Associate Editor Melissa A. Simon, MD, MPH, about the use, effectiveness, and potential side effects of Opill. Related Content: Over-the-Counter Progestin-Only Oral Contraceptives

Interview with John M. Ruiz, PhD, USPSTF member and coauthor of Screening and Preventive Interventions for Oral Health in Children and Adolescents Aged 5 to 17 Years, and Screening and Preventive Interventions for Oral Health in Adults: US Preventive Services Task Force Recommendation Statements. Hosted by JAMA Editor in Chief Kirsten Bibbins-Domingo, PhD, MD, MAS. Related Content: Screening, Referral, Behavioral Counseling, and Preventive Interventions for Oral Health in Children and Adolescents Aged 5 to 17 Years Screening and Preventive Interventions for Oral Health in Children and Adolescents Aged 5 to 17 Years Screening and Preventive Interventions for Oral Health in Adults A Call for More Oral Health Research in Primary Care Dental Caries in Adults, Adolescents, and Children Screening, Referral, Behavioral Counseling, and Preventive Interventions for Oral Health in Adults